FR08C0034I1 - Utilisation du composant neurotoxique de la toxine botulinique pour traiter les spasmes musculaires - Google Patents

Utilisation du composant neurotoxique de la toxine botulinique pour traiter les spasmes musculaires

Info

Publication number: FR08C0034I1
Authority: FR; France
Prior art keywords: botulinum toxin; muscle spasms; neurotoxic component; treat muscle; treat
Prior art date: 1993-12-28
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Active

Application number

FR08C0034C

Other languages

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Allergan Inc

Original Assignee

Allergan Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-12-28

Filing date

2008-08-27

Publication date

2008-09-26

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22634387&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FR08C0034(I1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2008-08-27 Application filed by Allergan Inc filed Critical Allergan Inc

2008-09-26 Publication of FR08C0034I1 publication Critical patent/FR08C0034I1/fr

Status Active legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
- A61K38/4893—Botulinum neurotoxin (3.4.24.69)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/06—Anti-spasmodics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Public Health (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Pain & Pain Management (AREA)
Physical Education & Sports Medicine (AREA)
Rheumatology (AREA)
Urology & Nephrology (AREA)
Orthopedic Medicine & Surgery (AREA)
Cardiology (AREA)
Pulmonology (AREA)
Heart & Thoracic Surgery (AREA)
Dermatology (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Ophthalmology & Optometry (AREA)
Vascular Medicine (AREA)
Reproductive Health (AREA)
Psychology (AREA)
Psychiatry (AREA)
Hospice & Palliative Care (AREA)
Otolaryngology (AREA)
Endocrinology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Epidemiology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

FR08C0034C 1993-12-28 2008-08-27 Utilisation du composant neurotoxique de la toxine botulinique pour traiter les spasmes musculaires Active FR08C0034I1 (fr)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US17399693A	1993-12-28	1993-12-28
EP95906674A EP0737074B1 (fr)	1993-12-28	1994-12-16	Toxines botulinum utilisees dans le traitement de l'hyperhydrosis
EP99203920A EP1005867B2 (fr)	1993-12-28	1994-12-16	Toxines de botulinum pour la modulation des secretions controlées par le système cholinergique

Publications (1)

Publication Number	Publication Date
FR08C0034I1 true FR08C0034I1 (fr)	2008-09-26

Family

ID=22634387

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FR08C0034C Active FR08C0034I1 (fr)	1993-12-28	2008-08-27	Utilisation du composant neurotoxique de la toxine botulinique pour traiter les spasmes musculaires

Country Status (8)

Country	Link
EP (23)	EP1477183B1 (fr)
JP (33)	JP3238154B2 (fr)
AU (1)	AU688452B2 (fr)
CA (2)	CA2180011C (fr)
DE (23)	DE69434540T2 (fr)
ES (18)	ES2207910T5 (fr)
FR (1)	FR08C0034I1 (fr)
WO (1)	WO1995017904A2 (fr)

Families Citing this family (103)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9120306D0 (en)	1991-09-24	1991-11-06	Graham Herbert K	Method and compositions for the treatment of cerebral palsy
DE69435253D1 (de)	1993-06-10	2009-12-31	Allergan Inc	Behandlung von neuromusculaeren Störungen und Zuständen mit verschiedenen botulism Serotypen
DE69434540T2 (de) *	1993-12-28	2009-06-18	Allergan, Inc., Irvine	Neurotoxisches Komponente von Botulinumtoxinen zur Behandlung von zervikaler Dystonie
US6974578B1 (en) *	1993-12-28	2005-12-13	Allergan, Inc.	Method for treating secretions and glands using botulinum toxin
US8187612B2 (en)	1993-12-28	2012-05-29	Allergan, Inc.	Use of the neurotoxic component of a botulinum toxin for treating a spastic muscle
US8557256B2 (en)	1993-12-28	2013-10-15	Allergan, Inc.	Treatment for cervical dystonia with the neurotoxic component of a botulinum toxin
AU2007202480B2 (en) *	1993-12-28	2009-01-29	Allergan, Inc.	Method for treating pain associated with a muscle disorder
ATE215832T1 (de) *	1994-05-09	2002-04-15	William J Binder	Botulinumtoxin zur reduktion von migraine - kopfschmerzen
US5721215A (en) *	1996-03-20	1998-02-24	Allergan	Injectable therapy for control of muscle spasms and pain related to muscle spasms
US6699966B1 (en)	1996-07-08	2004-03-02	University Of Massachusetts	Proteins within the type E botulinum neurotoxin complex
US6780413B2 (en)	1996-09-19	2004-08-24	The United States Of America As Represented By The Department Of Health And Human Services	Immunotoxin (mAB-RICIN) for the treatment of focal movement disorders
EP1949909B1 (fr)	1997-07-15	2014-01-08	The Regents of the University of Colorado, a body corporate	Utilisation de thérapie à base de toxine botulique pour le traitement d'un dysfonctionnement de type pulsion
US7470431B2 (en)	1997-07-15	2008-12-30	The Regents Of The University Of Colorado	Use of neurotoxin therapy for treatment of urological-neurological disorders associated with prostate cancer
US7449192B2 (en)	1997-07-15	2008-11-11	The Regents Of The University Of Colorado	Use of neurotoxin therapy for treatment of urologic and related disorders related to neurogenic bladder dysfunction
AU2008201535C1 (en) *	1997-07-15	2013-09-12	Allergan, Inc.	Use of neurotoxin therapy for treatment of urologic and related disorders
AU2006225233C1 (en) *	1997-07-15	2011-02-10	Allergan, Inc.	Use of neurotoxin therapy for treatment of urologic and related disorders
US9066943B2 (en)	1997-07-15	2015-06-30	The Regents Of The University Of Colorado	Use of botulinum toxin therapy for treatment of urological neurological conditions
US7455845B2 (en)	1997-07-15	2008-11-25	The Regents Of The University Of Colorado	Use of neurotoxin therapy for treatment of urologic and related disorders related to lowering elevated bladder pressure
US6063768A (en) *	1997-09-04	2000-05-16	First; Eric R.	Application of botulinum toxin to the management of neurogenic inflammatory disorders
GB9721189D0 (en)	1997-10-08	1997-12-03	Speywood Lab The Limited	Analgesic conjugates
WO1999037326A1 (fr)	1998-01-26	1999-07-29	University Of Massachusetts	Hemagglutinine biologiquement active tiree du clostridium botulinum de type a et procedes d'utilisation
US20040071736A1 (en)	1998-08-25	2004-04-15	Health Protection Agency	Methods and compounds for the treatment of mucus hypersecretion
US8790897B2 (en)	1998-08-25	2014-07-29	Syntaxin Ltd.	Treatment of mucus hypersecretion
GB9818548D0 (en) *	1998-08-25	1998-10-21	Microbiological Res Authority	Treatment of mucas hypersecretion
TW574036B (en)	1998-09-11	2004-02-01	Elan Pharm Inc	Stable liquid compositions of botulinum toxin
DE19856897A1 (de) *	1998-12-10	2000-06-15	Biotecon Ges Fuer Biotechnologische Entwicklung & Consulting Mbh	Therapeutikum zur Unterdrückung von Schnarchgeräuschen
DE19925739A1 (de)	1999-06-07	2000-12-21	Biotecon Ges Fuer Biotechnologische Entwicklung & Consulting Mbh	Therapeutikum mit einem Botulinum-Neurotoxin
US6977080B1 (en) *	1999-08-10	2005-12-20	Allergan, Inc.	Intrapericardial botulinum toxin treatment for bradycardia
US6767544B2 (en) *	2002-04-01	2004-07-27	Allergan, Inc.	Methods for treating cardiovascular diseases with botulinum toxin
GB9922554D0 (en)	1999-09-23	1999-11-24	Microbiological Res Authority	Inhibition of secretion from non-neuronal cells
US7838008B2 (en)	1999-12-07	2010-11-23	Allergan, Inc.	Methods for treating diverse cancers
US6139845A (en) *	1999-12-07	2000-10-31	Allergan Sales, Inc.	Method for treating cancer with a neurotoxin
US6261572B1 (en)	2000-01-11	2001-07-17	Allergan Sales, Inc.	Method for treating a pancreatic disorder with a neurotoxin
US6337075B1 (en)	2000-01-11	2002-01-08	Allergan Sales, Inc.	Methods for treating diabetes
US6143306A (en) *	2000-01-11	2000-11-07	Allergan Sales, Inc.	Methods for treating pancreatic disorders
US6524580B1 (en) *	2000-02-15	2003-02-25	Allergan Sales, Inc.	Method for treating thyroid disorders
US6358513B1 (en) *	2000-02-15	2002-03-19	Allergan Sales, Inc.	Method for treating Hashimoto's thyroiditis
US6328977B1 (en) *	2000-02-22	2001-12-11	Allergan Sales, Inc.	Method for treating hyperparathyroidism
US6464986B1 (en)	2000-04-14	2002-10-15	Allegan Sales, Inc.	Method for treating pain by peripheral administration of a neurotoxin
US6565870B1 (en)	2000-04-28	2003-05-20	Allergan, Inc.	Methods for treating bone tumors
US6306403B1 (en) *	2000-06-14	2001-10-23	Allergan Sales, Inc.	Method for treating parkinson's disease with a botulinum toxin
WO2002009743A1 (fr) *	2000-08-02	2002-02-07	Allergan Sales, Inc.	Methode de traitement d'un neoplasme
US6423319B1 (en) *	2000-10-04	2002-07-23	Allergan Sales, Inc.	Methods for treating muscle injuries
US6827931B1 (en) *	2000-10-20	2004-12-07	Allergan, Inc.	Method for treating endocrine disorders
US7255865B2 (en)	2000-12-05	2007-08-14	Allergan, Inc.	Methods of administering botulinum toxin
US20020086036A1 (en)	2000-12-05	2002-07-04	Allergan Sales, Inc.	Methods for treating hyperhidrosis
ITUD20010002A1 (it)	2001-01-05	2002-07-05	Univ Degli Studi Udine	Uso della tossina botulinica per la soluzione di patologie articolari, in particolare della coxartrosi, della epicondilite e della patolo
GB0111146D0 (en) *	2001-05-04	2001-06-27	Imp College Innovations Ltd	Methods
JP2003009897A (ja)	2001-07-03	2003-01-14	Keiji Oguma	ボツリヌス毒素の分離・精製法
KR20030018827A (ko) *	2001-08-31	2003-03-06	서구일	Ａ형 보툴리눔 독소를 유효성분으로 포함하는 신경차단제,및 이를 이용한 교감신경절 차단의 적응질환 치료제
US6623742B2 (en)	2001-09-17	2003-09-23	Allergan, Inc.	Methods for treating fibromyalgia
US7255866B2 (en)	2001-09-17	2007-08-14	Allergan, Inc.	Botulinum toxin therapy for fibromyalgia
US20030113349A1 (en)	2001-12-18	2003-06-19	Coleman William P.	Topically applied clostridium botulinum toxin compositions and treatment methods
US6921538B2 (en) *	2002-05-10	2005-07-26	Allergan, Inc.	Therapeutic treatments for neuropsychiatric disorders
US6776991B2 (en)	2002-06-26	2004-08-17	Allergan, Inc.	Methods for treating priapism
US20040009180A1 (en) *	2002-07-11	2004-01-15	Allergan, Inc.	Transdermal botulinum toxin compositions
CA2501856A1 (fr) *	2002-10-15	2004-04-29	Allergan, Inc.	Therapies et procedures dentaires a base de toxine botulinique
US20040086532A1 (en)	2002-11-05	2004-05-06	Allergan, Inc.,	Botulinum toxin formulations for oral administration
US7238357B2 (en)	2002-11-05	2007-07-03	Allergan, Inc.	Methods for treating ulcers and gastroesophageal reflux disease
WO2004078199A1 (fr) *	2003-03-06	2004-09-16	Botulinum Toxin Research Associates, Inc.	Traitment de kystes de meibomius et d'orgelets chroniques avec la toxine botulique
WO2004078201A1 (fr) *	2003-03-06	2004-09-16	Botulinum Toxin Research Associates, Inc.	Traitement des cephalees et des douleurs faciales chroniques associees a la sinusite au moyen de toxine botulinique
US7220422B2 (en)	2003-05-20	2007-05-22	Allergan, Inc.	Methods and compositions for treating eye disorders
FR2857595B1 (fr) *	2003-07-18	2005-10-07	Sod Conseils Rech Applic	Utilisation de toxine botulique pour preparer un medicament destine a prevenir ou traiter les troubles sonores lies a l'agonie
US8734810B2 (en)	2003-10-29	2014-05-27	Allergan, Inc.	Botulinum toxin treatments of neurological and neuropsychiatric disorders
US8609113B2 (en)	2003-10-29	2013-12-17	Allergan, Inc.	Botulinum toxin treatments of depression
US8609112B2 (en)	2003-10-29	2013-12-17	Allergan, Inc.	Botulinum toxin treatments of depression
US8617572B2 (en)	2003-10-29	2013-12-31	Allergan, Inc.	Botulinum toxin treatments of depression
US7276244B2 (en)	2004-02-12	2007-10-02	Philip Radovic	Methods of treating abnormalities of the first metatarsophalangeal joint of the foot
EP1715888B1 (fr) *	2004-02-12	2007-08-01	Philip Radovic	Traitement des anomalies de la premiere articulation metatarsophalangienne du pied
US20050191321A1 (en) *	2004-02-26	2005-09-01	Allergan, Inc.	Methods for treating headache
SG150568A1 (en)	2004-03-03	2009-03-30	Revance Therapeutics Inc	Compositions and methods for topical application and transdermal delivery of botulinum toxins
CN101083907B (zh)	2004-03-03	2012-10-10	雷文斯治疗公司	用于局部诊断剂和治疗剂运输的组合物和方法
US9211248B2 (en)	2004-03-03	2015-12-15	Revance Therapeutics, Inc.	Compositions and methods for topical application and transdermal delivery of botulinum toxins
AU2006218431B2 (en)	2005-03-03	2012-12-06	Revance Therapeutics, Inc.	Compositions and methods for topical application and transdermal delivery of botulinum toxins
EP1747782A1 (fr)	2005-07-19	2007-01-31	Cesare Montecucco	Produits pour l'application topique comprenant de lysophospholipids et d'acides gras
US7910116B2 (en)	2005-08-24	2011-03-22	Allergan, Inc.	Use of a botulinum toxin to improve gastric emptying and/or to treat GERD
CN103126971A (zh)	2005-11-17	2013-06-05	雷文斯治疗公司	减少非毒素蛋白质的肉毒杆菌毒素组合物和其局部施用及透皮递送方法
WO2007095486A1 (fr) *	2006-02-13	2007-08-23	Allergan, Inc.	Procedes de traitement des blepharospasmes reposant sur des composants de cyclosporine
US7794386B2 (en)	2006-03-15	2010-09-14	Allergan, Inc.	Methods for facilitating weight loss
US7811586B2 (en)	2006-05-02	2010-10-12	Allergan, Inc.	Methods for alleviating testicular pain
FR2902341B1 (fr)	2006-06-16	2011-02-25	Scras	Utilisation therapeutique simultanee, separee ou etalee dans le temps d'au moins une neurotoxine botulique, et d'au moins un derive opiace
US10792344B2 (en)	2006-06-29	2020-10-06	Merz Pharma Gmbh & Co. Kgaa	High frequency application of botulinum toxin therapy
AR061669A1 (es) *	2006-06-29	2008-09-10	Merz Pharma Gmbh & Co Kgaa	Aplicacion de alta frecuencia de terapia con toxina botulinica
FR2907680B1 (fr) *	2006-10-27	2012-12-28	Scras	Utilisation therapeutique d'au moins une neurotoxine botulique dans le traitement de la douleur induite par au moins un agent anti-cancereux
FR2910327B1 (fr)	2006-12-22	2013-04-26	Scras	Utilisation d'au moins une neurotoxine botulique pour traiter la douleur induite par les traitements therapeutiques du virus du sida.
US8002717B2 (en)	2007-03-30	2011-08-23	Anders Fagergren	Quantification of mechanical and neural contributions to spasticity
JP5401457B2 (ja)	2007-07-26	2014-01-29	ルバンスセラピュティックスインク．	抗菌ペプチド、組成物及びその使用方法
EP2072039A1 (fr) *	2007-12-21	2009-06-24	Merz Pharma GmbH & Co.KGaA	Utilisation d'un composant neurotoxique du complexe de la toxine du Clostridium botulinum pour réduire ou prévenir les effets latéraux
US8470337B2 (en)	2008-03-13	2013-06-25	Allergan, Inc.	Therapeutic treatments using botulinum neurotoxin
FR2930447B1 (fr)	2008-04-25	2010-07-30	Sod Conseils Rech Applic	Utilisation therapeutique d'au moins une neurotoxine botulique dans le traitement de la douleur dans le cas de la neuropathie diabetique
US20100124559A1 (en) *	2008-11-20	2010-05-20	Allergan, Inc.	Early Treatment and Prevention of Increased Muscle Tonicity
DK2379104T3 (en)	2008-12-31	2018-04-30	Revance Therapeutics Inc	Injectable botulinum toxin formulations
US9340587B2 (en)	2009-06-25	2016-05-17	Revance Therapeutics, Inc.	Albumin-free botulinum toxin formulations
US8147848B2 (en)	2009-08-26	2012-04-03	Allergan, Inc.	Method for treating premature ejaculation with a botulinum neurotoxin
MX370929B (es)	2012-10-28	2020-01-08	Revance Therapeutics Inc	Composiciones y usos de las mismas para el tratamiento seguro de la rinitis.
RU2545453C2 (ru) *	2013-03-21	2015-03-27	Государственное бюджетное образовательное учреждение высшего профессионального образования "Самарский государственный медицинский университет" Министерства здравоохранения Российской Федерации	Способ лечения переломов нижней челюсти
US10149893B2 (en)	2013-09-24	2018-12-11	Allergan, Inc.	Methods for modifying progression of osteoarthritis
KR101677710B1 (ko) *	2014-06-30	2016-11-21	(주)메디톡스	보툴리눔 독소를 유효성분으로 포함하는 골관절염 치료용 약제학적 조성물 및 그를 이용한 골관절염 치료 방법
US11484580B2 (en)	2014-07-18	2022-11-01	Revance Therapeutics, Inc.	Topical ocular preparation of botulinum toxin for use in ocular surface disease
SI3432916T1 (sl)	2016-09-13	2020-01-31	Allergan, Inc.	Stabilizirani ne-protein klostridijski toksin sestavki
EP3843777A4 (fr) *	2018-08-28	2022-05-04	Ira Sanders	Agents thérapeutiques pour la peau
RU2732204C1 (ru) *	2020-01-28	2020-09-14	Частное учреждение образовательная организация высшего образования "Медицинский университет "Реавиз"	Способ лечения головных болей напряжения по Гурову-Левину
KR102710632B1 (ko) *	2020-10-07	2024-09-27	주식회사 프로톡스	보툴리눔 독소의 진공 건조 방법

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4362731A (en) *	1980-09-01	1982-12-07	Sandoz Ltd.	Myotonolytic use of 4,5,6,7-tetrahydroisoxazolo [5,4-c] pyridin-3-ol and derivatives thereof
US4664911A (en)	1983-06-21	1987-05-12	Board Of Regents, University Of Texas System	Immunotoxin conjugates employing toxin B chain moieties
US5053005A (en)	1989-04-21	1991-10-01	Gary E. Borodic	Chemomodulation of curvature of the juvenile spine
GB9022250D0 (en) *	1990-10-12	1990-11-28	Glaxo Group Ltd	Medicaments
GB9120306D0 (en) *	1991-09-24	1991-11-06	Graham Herbert K	Method and compositions for the treatment of cerebral palsy
AU4646393A (en) *	1992-06-23	1994-01-24	Interactive Biologics Associates	Pharmaceutical composition containing botulinum b complex
AU6030494A (en) *	1993-01-15	1994-08-15	Associated Synapse Biologics	Method for treating myofascial pain syndrome
DE69435253D1 (de) *	1993-06-10	2009-12-31	Allergan Inc	Behandlung von neuromusculaeren Störungen und Zuständen mit verschiedenen botulism Serotypen
DE69432299T2 (de) *	1993-06-10	2003-12-11	Allergan, Inc.	Multiple Botulinum Toxine zur Behandlung von neuromuskulären Störungen und Zuständen
US5437291A (en) *	1993-08-26	1995-08-01	Univ Johns Hopkins	Method for treating gastrointestinal muscle disorders and other smooth muscle dysfunction
DE69434540T2 (de) *	1993-12-28	2009-06-18	Allergan, Inc., Irvine	Neurotoxisches Komponente von Botulinumtoxinen zur Behandlung von zervikaler Dystonie
US5766605A (en) *	1994-04-15	1998-06-16	Mount Sinai School Of Medicine Of The City University Of New York	Treatment of autonomic nerve dysfunction with botulinum toxin
ATE215832T1 (de) *	1994-05-09	2002-04-15	William J Binder	Botulinumtoxin zur reduktion von migraine - kopfschmerzen
JP2001104991A (ja) *	1999-10-12	2001-04-17	Toyoaki Kubota	循環水の有機質除去剤

1994
- 1994-12-16 DE DE69434540T patent/DE69434540T2/de not_active Expired - Lifetime
- 1994-12-16 EP EP04019047A patent/EP1477183B1/fr not_active Revoked
- 1994-12-16 EP EP05018367A patent/EP1600163B1/fr not_active Expired - Lifetime
- 1994-12-16 EP EP99203920A patent/EP1005867B2/fr not_active Expired - Lifetime
- 1994-12-16 DE DE69435194T patent/DE69435194D1/de not_active Expired - Lifetime
- 1994-12-16 DE DE69435302T patent/DE69435302D1/de not_active Expired - Lifetime
- 1994-12-16 DE DE69434008T patent/DE69434008T2/de not_active Expired - Lifetime
- 1994-12-16 ES ES99203920T patent/ES2207910T5/es not_active Expired - Lifetime
- 1994-12-16 AU AU15162/95A patent/AU688452B2/en not_active Ceased
- 1994-12-16 DE DE69434535T patent/DE69434535T2/de not_active Revoked
- 1994-12-16 ES ES04019046T patent/ES2332905T3/es not_active Expired - Lifetime
- 1994-12-16 EP EP07002714A patent/EP1790352B1/fr not_active Expired - Lifetime
- 1994-12-16 DE DE69435249T patent/DE69435249D1/de not_active Expired - Lifetime
- 1994-12-16 DE DE122009000038C patent/DE122009000038I1/de active Pending
- 1994-12-16 EP EP01118793A patent/EP1147776B1/fr not_active Expired - Lifetime
- 1994-12-16 DE DE122008000042C patent/DE122008000042I1/de active Pending
- 1994-12-16 EP EP01118792A patent/EP1147775B1/fr not_active Expired - Lifetime
- 1994-12-16 ES ES03015589T patent/ES2242126T3/es not_active Expired - Lifetime
- 1994-12-16 CA CA002180011A patent/CA2180011C/fr not_active Expired - Lifetime
- 1994-12-16 ES ES08017803T patent/ES2347384T3/es not_active Expired - Lifetime
- 1994-12-16 DE DE69428813T patent/DE69428813T2/de not_active Expired - Lifetime
- 1994-12-16 JP JP51812795A patent/JP3238154B2/ja not_active Expired - Lifetime
- 1994-12-16 DE DE69435276T patent/DE69435276D1/de not_active Expired - Lifetime
- 1994-12-16 ES ES00203294T patent/ES2246800T3/es not_active Expired - Lifetime
- 1994-12-16 DE DE69435116T patent/DE69435116D1/de not_active Expired - Lifetime
- 1994-12-16 EP EP00203294A patent/EP1072270B1/fr not_active Expired - Lifetime
- 1994-12-16 EP EP04019046A patent/EP1502600B1/fr not_active Expired - Lifetime
- 1994-12-16 ES ES97200028T patent/ES2163090T3/es not_active Expired - Lifetime
- 1994-12-16 DE DE69435149T patent/DE69435149D1/de not_active Expired - Lifetime
- 1994-12-16 EP EP99203735A patent/EP1010431B2/fr not_active Expired - Lifetime
- 1994-12-16 EP EP04018914A patent/EP1486214A1/fr not_active Withdrawn
- 1994-12-16 ES ES07002714T patent/ES2309973T3/es not_active Expired - Lifetime
- 1994-12-16 EP EP03015589A patent/EP1366770B1/fr not_active Revoked
- 1994-12-16 ES ES05018368T patent/ES2334357T3/es not_active Expired - Lifetime
- 1994-12-16 EP EP97200028A patent/EP0770395B1/fr not_active Expired - Lifetime
- 1994-12-16 DE DE122008000043C patent/DE122008000043I1/de active Pending
- 1994-12-16 ES ES95906674T patent/ES2159624T3/es not_active Expired - Lifetime
- 1994-12-16 CA CA002682117A patent/CA2682117A1/fr not_active Abandoned
- 1994-12-16 EP EP05018368A patent/EP1598077B1/fr not_active Expired - Lifetime
- 1994-12-16 WO PCT/US1994/014717 patent/WO1995017904A2/fr not_active Ceased
- 1994-12-16 EP EP03015590A patent/EP1366771B1/fr not_active Revoked
- 1994-12-16 DE DE69435321T patent/DE69435321D1/de not_active Expired - Lifetime
- 1994-12-16 EP EP06016208A patent/EP1757325B1/fr not_active Expired - Lifetime
- 1994-12-16 DE DE69435270T patent/DE69435270D1/de not_active Expired - Lifetime
- 1994-12-16 ES ES00203421T patent/ES2223393T3/es not_active Expired - Lifetime
- 1994-12-16 EP EP05006665.3A patent/EP1563843B1/fr not_active Expired - Lifetime
- 1994-12-16 EP EP04019048A patent/EP1488803B1/fr not_active Revoked
- 1994-12-16 EP EP08017803A patent/EP2027872B1/fr not_active Expired - Lifetime
- 1994-12-16 EP EP04000166A patent/EP1421948B1/fr not_active Expired - Lifetime
- 1994-12-16 ES ES03015590T patent/ES2251651T3/es not_active Expired - Lifetime
- 1994-12-16 DE DE69434443T patent/DE69434443T2/de not_active Revoked
- 1994-12-16 EP EP00203421A patent/EP1103267B1/fr not_active Revoked
- 1994-12-16 DE DE69433394T patent/DE69433394T3/de not_active Expired - Lifetime
- 1994-12-16 ES ES99203735T patent/ES2237033T5/es not_active Expired - Lifetime
- 1994-12-16 EP EP05017284A patent/EP1602379A1/fr not_active Withdrawn
- 1994-12-16 DE DE69435243T patent/DE69435243D1/de not_active Expired - Lifetime
- 1994-12-16 ES ES05018367T patent/ES2339865T3/es not_active Expired - Lifetime
- 1994-12-16 ES ES01118793T patent/ES2355491T3/es not_active Expired - Lifetime
- 1994-12-16 EP EP95906674A patent/EP0737074B1/fr not_active Expired - Lifetime
- 1994-12-16 DE DE69435330T patent/DE69435330D1/de not_active Expired - Lifetime
- 1994-12-16 DE DE69434610T patent/DE69434610T2/de not_active Expired - Lifetime
- 1994-12-16 DE DE69434511T patent/DE69434511T2/de not_active Expired - Lifetime
- 1994-12-16 DE DE69434319T patent/DE69434319T3/de not_active Expired - Lifetime
- 1994-12-16 ES ES01118792T patent/ES2319860T3/es not_active Expired - Lifetime
- 1994-12-16 ES ES04019047T patent/ES2247575T3/es not_active Expired - Lifetime
- 1994-12-16 DE DE69427869T patent/DE69427869T2/de not_active Expired - Lifetime
- 1994-12-16 ES ES04019048T patent/ES2248780T3/es not_active Expired - Lifetime
- 1994-12-16 EP EP05016177A patent/EP1591129B1/fr not_active Expired - Lifetime
- 1994-12-16 ES ES05016177T patent/ES2340172T3/es not_active Expired - Lifetime
2001
- 2001-07-16 JP JP2001214881A patent/JP2002104990A/ja active Pending
- 2001-07-16 JP JP2001214890A patent/JP2002087988A/ja active Pending
- 2001-07-16 JP JP2001214889A patent/JP2002087987A/ja active Pending
- 2001-07-16 JP JP2001214887A patent/JP2002087986A/ja not_active Withdrawn
- 2001-07-16 JP JP2001214891A patent/JP2002097156A/ja not_active Withdrawn
- 2001-07-16 JP JP2001214886A patent/JP2002087985A/ja active Pending
- 2001-07-16 JP JP2001214883A patent/JP2002114706A/ja not_active Withdrawn
- 2001-07-16 JP JP2001214884A patent/JP2002087984A/ja active Pending
- 2001-07-16 JP JP2001214885A patent/JP2002097145A/ja active Pending
- 2001-07-16 JP JP2001214888A patent/JP2002068989A/ja not_active Withdrawn
- 2001-07-16 JP JP2001214882A patent/JP2002104991A/ja not_active Withdrawn
2006
- 2006-01-26 JP JP2006017860A patent/JP2006160756A/ja not_active Withdrawn
- 2006-01-26 JP JP2006017859A patent/JP2006160755A/ja not_active Withdrawn
- 2006-01-26 JP JP2006017858A patent/JP2006160754A/ja not_active Withdrawn
- 2006-01-26 JP JP2006017857A patent/JP2006160753A/ja not_active Withdrawn
2007
- 2007-06-13 JP JP2007156168A patent/JP2007262086A/ja not_active Withdrawn
- 2007-09-26 JP JP2007248742A patent/JP2008056683A/ja not_active Withdrawn
- 2007-09-26 JP JP2007248739A patent/JP2008037877A/ja not_active Withdrawn
- 2007-09-26 JP JP2007248736A patent/JP2008056682A/ja not_active Withdrawn
- 2007-09-26 JP JP2007248745A patent/JP2008031176A/ja not_active Withdrawn
- 2007-10-26 JP JP2007278365A patent/JP2008063339A/ja not_active Withdrawn
2008
- 2008-08-27 FR FR08C0034C patent/FR08C0034I1/fr active Active
2010
- 2010-05-19 JP JP2010115454A patent/JP2010209105A/ja not_active Withdrawn
- 2010-05-19 JP JP2010115469A patent/JP2010202660A/ja not_active Withdrawn
- 2010-05-19 JP JP2010115472A patent/JP2010202661A/ja not_active Withdrawn
- 2010-05-19 JP JP2010115462A patent/JP2010202659A/ja not_active Withdrawn
2012
- 2012-05-10 JP JP2012108649A patent/JP2012167114A/ja active Pending
- 2012-05-10 JP JP2012108656A patent/JP2012188433A/ja active Pending
- 2012-05-10 JP JP2012108662A patent/JP2012167117A/ja active Pending
- 2012-05-10 JP JP2012108652A patent/JP2012167115A/ja active Pending
- 2012-05-10 JP JP2012108658A patent/JP2012167116A/ja active Pending
- 2012-05-23 JP JP2012117085A patent/JP2012197287A/ja active Pending
- 2012-09-10 JP JP2012198070A patent/JP2013006865A/ja active Pending

Also Published As

Publication number	Publication date
DE69434511T2 (de)	2006-07-13
ES2319860T3 (es)	2009-05-14
ES2163090T3 (es)	2002-01-16
AU1516295A (en)	1995-07-17
CA2180011C (fr)	2001-05-15
EP1005867A2 (fr)	2000-06-07
ES2207910T3 (es)	2004-06-01
EP1488803A1 (fr)	2004-12-22
EP1421948A2 (fr)	2004-05-26
EP1790352A1 (fr)	2007-05-30
JP3238154B2 (ja)	2001-12-10
JP2002068989A (ja)	2002-03-08
EP1005867A3 (fr)	2001-06-13
EP1366771A3 (fr)	2003-12-10
ES2237033T3 (es)	2005-07-16
JP2012188433A (ja)	2012-10-04
ES2251651T3 (es)	2008-07-16
DE69434319D1 (de)	2005-05-04
DE69434540D1 (de)	2009-03-26
JP2002104990A (ja)	2002-04-10
JP2002087984A (ja)	2002-03-27
ES2355491T3 (es)	2011-03-28
DE69427869D1 (de)	2001-09-06
EP1563843B1 (fr)	2013-08-07
JP2008031176A (ja)	2008-02-14
ES2347384T3 (es)	2010-10-28
EP1005867B1 (fr)	2003-12-03
EP1366771B1 (fr)	2008-03-26
JP2006160754A (ja)	2006-06-22
DE69435116D1 (de)	2008-08-21
JP2002097145A (ja)	2002-04-02
EP1366770A3 (fr)	2004-03-17
DE69435249D1 (de)	2009-12-17
EP1421948B1 (fr)	2008-10-08
DE69435243D1 (de)	2009-11-19
EP1010431A3 (fr)	2001-05-16
EP1502600B1 (fr)	2009-10-07
JP2010209105A (ja)	2010-09-24
ES2340172T3 (es)	2010-05-31
JP2002114706A (ja)	2002-04-16
EP1421948A3 (fr)	2004-06-16
EP1600163A1 (fr)	2005-11-30
ES2247575T3 (es)	2006-03-01
EP1147775A3 (fr)	2003-01-15
DE69433394T3 (de)	2010-08-12
EP1477183A1 (fr)	2004-11-17
JP2002087987A (ja)	2002-03-27
HK1070831A1 (en)	2005-06-30
EP1103267B1 (fr)	2004-09-15
DE69434319T3 (de)	2011-02-17
EP1147776B1 (fr)	2010-12-15
EP1010431B1 (fr)	2005-03-30
ES2339865T3 (es)	2010-05-26
CA2682117A1 (fr)	1995-07-06
JP2012197287A (ja)	2012-10-18
JP2012167117A (ja)	2012-09-06
ES2332905T3 (es)	2010-02-15
DE69434511D1 (de)	2006-03-02
DE69434535D1 (de)	2005-12-08
JP2002087988A (ja)	2002-03-27
EP2027872B1 (fr)	2010-07-14
ES2223393T3 (es)	2005-03-01
DE69434540T2 (de)	2009-06-18
WO1995017904A2 (fr)	1995-07-06
EP1598077A1 (fr)	2005-11-23
EP0770395B1 (fr)	2001-10-24
EP1602379A1 (fr)	2005-12-07
JPH09507234A (ja)	1997-07-22
EP1010431A2 (fr)	2000-06-21
DE69435302D1 (de)	2010-08-26
JP2002104991A (ja)	2002-04-10
EP1366770B1 (fr)	2005-07-27
EP1010431B2 (fr)	2010-07-14
ES2237033T5 (es)	2010-10-29
EP1477183B1 (fr)	2005-11-02
DE69435321D1 (de)	2010-12-16
DE69427869T2 (de)	2002-04-11
DE122008000042I1 (de)	2009-01-02
AU688452B2 (en)	1998-03-12
EP1600163B1 (fr)	2010-02-17
DE69434008T2 (de)	2005-09-22
EP1147776A2 (fr)	2001-10-24
HK1033274A1 (en)	2001-08-24
JP2002087986A (ja)	2002-03-27
EP1591129B1 (fr)	2010-02-24
EP1502600A1 (fr)	2005-02-02
DE122009000038I1 (de)	2009-11-05
DE69434319T2 (de)	2006-03-09
JP2002097156A (ja)	2002-04-02
EP2027872A1 (fr)	2009-02-25
ES2334357T3 (es)	2010-03-09
JP2008056683A (ja)	2008-03-13
JP2002087985A (ja)	2002-03-27
DE69434443D1 (de)	2005-09-01
DE69435330D1 (de)	2011-01-27
DE69428813T2 (de)	2002-04-04
ES2309973T3 (es)	2008-12-16
EP1072270A3 (fr)	2002-08-07
EP1366770A2 (fr)	2003-12-03
EP1757325B1 (fr)	2010-11-03
EP1147775A2 (fr)	2001-10-24
ES2207910T5 (es)	2010-05-21
CA2180011A1 (fr)	1995-07-06
JP2006160755A (ja)	2006-06-22
EP0737074B1 (fr)	2001-08-01
JP2010202661A (ja)	2010-09-16
HK1064599A1 (en)	2005-02-04
EP1147775B1 (fr)	2009-03-04
JP2008056682A (ja)	2008-03-13
DE69434443T2 (de)	2006-05-24
DE69435149D1 (de)	2008-11-20
DE69434610D1 (de)	2008-08-21
DE69434535T2 (de)	2006-07-20
EP1790352B1 (fr)	2008-07-09
EP1366771A2 (fr)	2003-12-03
DE69434610T2 (de)	2008-11-27
EP0737074A1 (fr)	1996-10-16
EP1147776A3 (fr)	2003-01-15
EP1598077B1 (fr)	2009-11-04
DE69434008D1 (de)	2004-10-21
EP1591129A3 (fr)	2005-11-16
JP2006160753A (ja)	2006-06-22
JP2008037877A (ja)	2008-02-21
ES2159624T3 (es)	2001-10-16
DE69433394D1 (de)	2004-01-15
EP1005867B2 (fr)	2010-02-17
HK1072375A1 (en)	2005-08-26
EP1103267A1 (fr)	2001-05-30
JP2012167115A (ja)	2012-09-06
WO1995017904A3 (fr)	1995-10-19
JP2012167116A (ja)	2012-09-06
HK1106700A1 (en)	2008-03-20
DE69433394T2 (de)	2004-10-14
EP1591129A2 (fr)	2005-11-02
JP2010202660A (ja)	2010-09-16
JP2006160756A (ja)	2006-06-22
EP1488803B1 (fr)	2008-03-26
JP2013006865A (ja)	2013-01-10
DE69435270D1 (de)	2010-04-01
JP2012167114A (ja)	2012-09-06
JP2007262086A (ja)	2007-10-11
DE122008000043I1 (de)	2008-11-20
DE69428813D1 (de)	2001-11-29
ES2246800T3 (es)	2006-03-01
JP2008063339A (ja)	2008-03-21
HK1071071A1 (en)	2005-07-08
EP1072270B1 (fr)	2005-10-19
EP1563843A1 (fr)	2005-08-17
EP1072270A2 (fr)	2001-01-31
DE69435194D1 (de)	2009-04-16
DE69435276D1 (de)	2010-04-08
EP0770395A1 (fr)	1997-05-02
ES2248780T3 (es)	2008-06-16
JP2010202659A (ja)	2010-09-16
EP1757325A1 (fr)	2007-02-28
ES2242126T3 (es)	2005-11-01
EP1486214A1 (fr)	2004-12-15

Publication	Publication Date	Title
FR08C0034I1 (fr)	2008-09-26	Utilisation du composant neurotoxique de la toxine botulinique pour traiter les spasmes musculaires
PT936908E (pt)	2002-08-30	Derivados anticonvulsivos uteis no tratamento de esclerose lateral amiotrofica (ela)
DE69432299D1 (de)	2003-04-24	Multiple Botulinum Toxine zur Behandlung von neuromuskulären Störungen und Zuständen
DE69631901D1 (de)	2004-04-22	Verfahren zur verminderung der korrosivität und acidität von rohöl
FR2533058B1 (fr)	1987-08-28	Composant de construction a isolation phonique et son utilisation pour la construction de superstructures, d'infrastructures, de tunnels et de vehicules
DE69429968D1 (de)	2002-04-04	Kolonne und Kolonnenvorrichtung für Flüssigchromatographie, und Verfahren zum Gebrauch dieser Kolonnenvorrichtung
FR2704743B1 (fr)	1997-05-30	Dispositif pour réduire la sensation de douleur.
DE69634103D1 (de)	2005-01-27	Gerät zum Oberflächenbearbeiten von heissgewalzten Stahlmaterialien
BR9505368A (pt)	1997-10-28	Composição cosmética ou dermatogógico água-em-óleo
EE200100511A (et)	2002-12-16	Meetod neuroloogiliste või neuropsühhiaatriliste häirete käitluseks
DE69603891D1 (de)	1999-09-30	Reduktion von hydrolysierbare Kationen in Rohölen
BR9405954A (pt)	1995-12-26	Compostos policíclicos e derivados dos mesmos composições farmacêuticas e método de tratamento de disfunção cognitiva ou neurológica
FR2699959B1 (fr)	1995-09-29	Procédé de déshydratation et/ou dessalage et de fractionnement simultané d'un effluent de gisement pétrolier.
MA23837A1 (fr)	1996-12-31	Benzamides pour le traitement de degenerescenses neurologiques
DE59401516D1 (de)	1997-02-20	Lenkeinrichtung für Gleiskettenlaufwerke
BR9302861A (pt)	1995-01-17	Escórias sintéticas para tratamento de aços líquidos
FI924250L (fi)	1994-03-24	Tien, lentokentän tai vastaavan puhdistuslaitteisto
DE69433027D1 (de)	2003-09-11	Mehrzwecke funktionelle Flüssigkeit für landwirtschaftliche Maschine oder Baumaschine
KR950018294U (ko)	1995-07-22	자동차의 스티어링 기어박스
KR950018178U (ko)	1995-07-22	자동차의 측면방향 이동장치
KR970001603U (ko)	1997-01-21	무한궤도 주행장치의 토사방지장치
DE59604915D1 (de)	2000-05-11	Entschwefelungsmittel zur koinjektions-behandlung von roheisenschmelzen
KR940019222U (ko)	1994-08-19	자동차용 조향중간축의 체결밴드
KR970001015A (ko)	1997-01-21	자동차의 조향축
FR2714843B1 (fr)	1996-02-16	Gant ou moufle pour la pratique du ski.